Normal human cells in culture exhibit limited proliferative potential (cellular senescence). Senescent cells have been found to produce an inhibitor of DNA synthesis that is not made by young cells. Our current hypothesis is that production of this inhibitor of DNA synthesis is the end point of a genetic program that results in cellular senescence. From cell hybrid studies we have determined that this genetic program is dominant and that the phenotype of immortality is recessive. The goal of this proposal is to understand what recessive changes have occurred in immortal cells. Part of the proposal focuses on immortalization of human cells by SV40 virus. From cell hybrid studies we have assigned 22 immortal human cell lines to three complementation groups for immortality. All immortal SV40-transformed cell lines assigned to the same complementation group, indicating that SV40 immortalizes human cells by the same processes. It is clear that the viral genome is not sufficient to maintain immortalization, because human cells containing a stably integrated and expressed viral genome exhibit limited division. Two possibilities remain: (i) The virus or viral gene products interact with some cellular gene to maintain immortalization, or (ii) a cellular gene is modified following viral integration and this gene alone maintains immortalization. In this proposal we will directly test the role of T antigen in the maintenance of immortalization by inactivating the T-antigen-coding sequences in the integrated viral genome of immortal SV40-transformed cells. If T antigen is required to maintain immortality, we will determine with which cellular genes this protein interacts. If T antigen is not required, we will determine whether the viral enhancer is involved in the maintenance of immortalization. The results will clearly demonstrate whether viral sequences are required to maintain immortality and aid in identification of cellular sequences involved. Another aim of this proposal is to determine whether immortal cell lines within any of the complementation groups for immortality are producing the inhibitor of DNA synthesis expressed in senescent cells. Cell lines that are producing the inhibitor will be analyzed to determine whether they have become immortal by expressing genes that act counter to the inhibitor. Cell lines that are not producing the inhibitor will be analyzed to determine whether they have become immortal because of transcriptional or translational block of the inhibitor gene, post- translational modification or inactivation of the inhibitor protein, or modifications in genes that regulate expression of the inhibitor gene.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG007123-03
Application #
3814106
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Duttaroy, A; Qian, J F; Smith, J S et al. (1997) Up-regulated P21CIP1 expression is part of the regulation quantitatively controlling serum deprivation-induced apoptosis. J Cell Biochem 64:434-46
Smith, J R; Nakanishi, M; Robetorye, R S et al. (1996) Studies demonstrating the complexity of regulation and action of the growth inhibitory gene SDI1. Exp Gerontol 31:327-35
Yang, L; Didenko, V V; Noda, A et al. (1995) Increased expression of p21Sdi1 in adrenocortical cells when they are placed in culture. Exp Cell Res 221:126-31
Kaul, S C; Wadhwa, R; Matsuda, Y et al. (1995) Mouse and human chromosomal assignments of mortalin, a novel member of the murine hsp70 family of proteins. FEBS Lett 361:269-72
Wadhwa, R; Pereira-Smith, O M; Reddel, R R et al. (1995) Correlation between complementation group for immortality and the cellular distribution of mortalin. Exp Cell Res 216:101-6
Nakanishi, M; Robetorye, R S; Pereira-Smith, O M et al. (1995) The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition. J Biol Chem 270:17060-3
Hensler, P J; Pereira-Smith, O M (1995) Human replicative senescence. A molecular study. Am J Pathol 147:1-8
Khaoustov, V I; Ozer, A; Smith, J R et al. (1995) Induction of senescent cell-derived inhibitor of DNA synthesis gene, SDI1, in hepatoblastoma (HepG2) cells arrested in the G2-phase of the cell cycle by 9-nitrocamptothecin. Lab Invest 73:118-27
Nakanishi, M; Robetorye, R S; Adami, G R et al. (1995) Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1. EMBO J 14:555-63
Aggarwal, B B; Totpal, K; LaPushin, R et al. (1995) Diminished responsiveness of senescent normal human fibroblasts to TNF-dependent proliferation and interleukin production is not due to its effect on the receptors or on the activation of a nuclear factor NF-kappa B. Exp Cell Res 218:381-8

Showing the most recent 10 out of 39 publications